BioSpectrum Asia Special Report - Innovation in Asia-Pacific Cold Chain Logistics
The Asia-Pacific region is witnessing rapid growth in life sciences and healthcare, driving an urgent need for robust temperature-controlled logistics (“cold chain”) to safely deliver pharmaceuticals, vaccines, biologics, and other sensitive products. In response, global logistics leaders are investing heavily in innovations, digital transformation, and resilient supply chain strategies to ensure end-to-end cold chain integrity. This report, part of BioSpectrum Asia’s special cold chain issue, highlights how key players – DHL, FedEx, UPS, EVA Air Cargo, DB Schenker, Agility, Bolloré Logistics, Maersk, CEVA Logistics, SF Express, Yusen Logistics – are building strategic capabilities and infrastructure across Asia-Pacific. Each of these companies is leveraging advanced technologies, quality standards, and network investments to maintain pharmaceutical products at required temperatures while enhancing visibility and reliability. Below, we provide an overview of each organization’s cold chain logistics initiatives, recent innovations, digital tools, and infrastructure investments in the APAC region.
-
Follow
-
0
-
Embed
-
Share
-
Upload
